Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

A Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects

ClinicalTrials.gov ID: NCT01144637

Public ClinicalTrials.gov record NCT01144637. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in Healthy, Vaccinia-Naïve Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A randomized, double-blind, placebo-controlled Phase III trial to evaluate immunogenicity and safety of three consecutive production lots of IMVAMUNE® (MVA-BN®) smallpox vaccine in healthy, vaccinia-naïve subjects.

Study identification

NCT ID
NCT01144637
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bavarian Nordic
Industry
Enrollment
4,005 participants

Conditions and interventions

Conditions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 40 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2013 (Type not available)
Primary completion
Nov 2013 (Actual)
Completion
Jun 2014 (Actual)
Last update posted
Jan 3, 2019

2013 – 2014

United States locations

U.S. sites
34
U.S. states
24
U.S. cities
34
Facility City State ZIP Site status
Alabama Vaccine Research Clinic Birmingham Alabama 35294 —
Anaheim Clinical Trials Anaheim California 92801 —
National Research Institute Los Angeles California 90057 —
Northern California Clinical Research Center (NCCRC) Redding California 96001 —
Therapeutics Clinical Research San Diego California 92123 —
Lynn Institute of the Rockies Colorado Springs Colorado 80907 —
Avail Clinical Research, LLC DeLand Florida 32720 —
Broward Research Group Hollywood Florida 33024 —
Accelovance Melbourne Melbourne Florida 32935 —
Southeast Regional Research Group Savannah Georgia 31405 —
Advanced Clinical Research, Inc. Meridian Idaho 83642 —
Accelovance Peoria Peoria Illinois 61602 —
Heartland Research Associates Augusta Kansas 67010 —
Heartland Research Associates, LLC Wichita Kansas 67207 —
Benchmark Research Metairie Louisiana 70006 —
QPS Bio-Kinetic Springfield Missouri 65802 —
Washington University in St. Louis, School of Medicine St Louis Missouri 63110 —
Meridian Clinical Research, LLC Omaha Nebraska 68134 —
Clinical Research Center of Nevada, LLC Las Vegas Nevada 89104 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Wake Research Associates Raleigh North Carolina 27612 —
Rapid Medical Research, Inc. Cleveland Ohio 44122 —
Family Practice Center of Wooster Wooster Ohio 44691 —
Lynn Health Science Institute Oklahoma City Oklahoma 73112 —
Columbia Research Group, Inc. Portland Oregon 97239 —
Omega Medical Research Warwick Rhode Island 02886 —
PMG Research of Charleston Mt. Pleasant South Carolina 29464 —
Holston Medical Group Bristol Tennessee 37620 —
Volunteer Research Group Knoxville Tennessee 37920 —
Benchmark Research Fort Worth Texas 76135 —
Tanner Clinic Layton Utah 84041 —
Advanced Clinical Research West Jordan Utah 84088 —
Clinical Research Associates of Tidewater Norfolk Virginia 23507 —
University Physicians Internal Medicine University Physicians & Surgeons, Inc. Huntington West Virginia 25701 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01144637, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 3, 2019 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01144637 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →